Variable, statistics | Estimate |
---|---|
Age in years, median (range) | 66.1 (22.8, 91.3) |
Gender males/females—ratio | 169/142 |
Location primary tumour | |
Colon, n (%) | 205 (65.9) |
Rectum, n (%) | 101 (32.5) |
Combined, n (%) | 5 (1.6) |
Synchronous metastasesa, n (%) | 157 (50.5) |
Disease-free intervalb in months, median (range) | 4.2 (−11, 131) |
Resections, n | 311 |
Hemihepatectomy/lobectomy, n (%) | 137 (44.1) |
Wedge/segment resections, n (%) | 174 (55.9) |
Simultaneous radio frequency ablation, n (%) | 12 (3.9) |
Two-stage resections with PVL, n (%) | 3 (1.0) |
Simultaneous colorectal cancer surgery, n (%) | 18 (5.8) |
R1 resections (<1 mm) | 63 (20.3) |
Extent of RM in millimeter, median (range) | 4 (0–50) |
Number of metastases, median (range) | 2 (1, 12) |
Metastases diameter in centimeter, median (range) | 3.0 (0.2, 15.0) |
Bilobar metastases, n (%) | 108 (34.7) |
Number of procedures/patient (1/2/3/4/5) | 254/42/11/3/1 |
Morbidity (Clavien-Dindo score 1/2/3/4/5) | 19/28/52/5/6 |
Outcome of chemotherapy (RECIST criteria) | |
Partial response, n (%) | 63 (56.2) |
Stable disease, n (%) | 42 (37.5) |
Progression, n (%) | 5 (4.4) |
Unknown, n (%) | 2 (1.8) |